The EMBO Journal (2011 Journal ( ) 30, 1415 Journal ( -1417 Journal ( . doi:10.1038 Journal ( /emboj.2011 In this issue of The EMBO Journal, Tanneberger et al demonstrate that Amer1/WTX, a tumour suppressor protein previously known for promoting b-catenin degradation and thus antagonizing Wnt signalling, is also required for LRP6 receptor phosphorylation and therefore activation of Wnt signalling. Amer1/WTX is recruited by PtdIns(4,5)P 2 to the plasma membrane, and in turn recruits the Axin-GSK3 complex and CK1c to phosphorylate LRP6. While dichotomic players like Amer1/WTX are common in Wnt signalling, these new findings add more intrigues to this enigmatic protein and pathway.
Wnt/b-catenin signalling controls embryogenesis and homeostasis, and has a central role in many diseases including cancer and osteoporosis (MacDonald et al, 2009 ). In the absence of an extracellular Wnt ligand, cytoplasmic b-catenin is phosphorylated and targeted for degradation via a complex assembled by the scaffolding protein Axin, the tumour suppressor APC (adenomatous polyposis coli), and kinases GSK3 and CKIa. Binding of a Wnt ligand to a frizzled (Fz) serpentine receptor and its coreceptor, low density lipoprotein receptor-related protein 6 (LRP6, or its relative LRP5), inhibits b-catenin phosphorylation and degradation, leading to increased b-catenin and its association with LEF/TCF DNAbinding factors for transcription of Wnt target genes (MacDonald et al, 2009) . Wnt-induced phosphorylation of LRP6 represents a key step in receptor activation. Most critical are phosphorylation events at multiple PPPSPxS motifs, which provide docking sites for Axin and are sequentially carried out by GSK3 and CKI (Tamai et al, 2004 , Zeng et al, 2005 . Other phosphorylation events include those that are performed by CKI (likely CKIg) at a S/T-rich cluster (Davidson et al, 2005) . This complex pattern of LRP6 phosphorylation is subjected to regulation by many components including Fz, Dishevelled (Dvl), and also Axin (Bilic et al, 2007; Zeng et al, 2008) (Figure 1 ). LRP6 phosphorylation also requires phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P 2 ), whose production is induced by Wnt through Dvl binding and activation of phosphatidylinositol 4-kinase type II a (PI4KIIa) and phosphatidylinositol-4-phosphate 5-kinase type I (PIP5KI) (Pan et al, 2008) . The mechanism by which PtdIns(4,5)P 2 promotes LRP6 phosphorylation has remained unclear and Tanneberger et al (2011) now demonstrate that Amer1/WTX (APC membrane recruitment 1/Wilms tumour gene on the X chromosome) is recruited by PtdIns(4,5)P 2 to the plasma membrane to promote LRP6 phosphorylation by Axin-GSK3 and CK1g.
Amer1 was initially identified as an APC-binding protein, which regulates APC cellular localization (Grohmann et al, 2007) . Amer1 is identical to WTX, which is mutated in some cases of Wilms tumour, a paediatric kidney cancer (Rivera P P P P P P P P P P P P P P P P P P P P P P P P P (Figure 1 ). Previous studies have demonstrated a critical role of the Axin-GSK3 complex in LRP6 phosphorylation (Zeng et al, 2005 (Zeng et al, , 2008 . Consistent with the findings of Amer1/WTX association with the Axin complex (Major et al, 2007) , Tanneberger et al found that Amer1/WTX recruited Axin and GSK3 to the plasma membrane, and that Amer1/WTX promotion of LRP6 phosphorylation relied on the Axin-binding domain of Amer1/WTX. The authors further illustrated the unusual scaffolding property of Amer1/WTX in its binding to CK1g and LRP6, providing a potential explanation for Amer1/WTX involvement in phosphorylation at PPPSPxS motifs (by GSK3 and CK1) and the S/T-rich cluster (by CK1g). Indeed a chimeric molecule between the LRP6 cytoplasmic domain and Amer1/WTX was sufficient to enhance LRP6 phosphorylation and signalling. The data provide a strong case for Amer1/WTX in mediating LRP6 phosphorylation through recruiting Axin-GSK3 and CK1g (Figure 1) . Amer1/WTX therefore appears to have two opposite functions in the Wnt pathway, analogous to those described for Axin, GSK3, and likely some CK1 members (Zeng et al, 2005 (Zeng et al, , 2008 . These proteins in the absence of Wnt stimulation promote b-catenin phosphorylation and thus antagonize Wnt signalling; but upon Wnt stimulation they switch sides to enhance LRP6 phosphorylation and activate Wnt signalling. These dual roles are nonetheless compatible with genetically defined tumour suppressor functions of WTX and Axin, as a loss of either results in elevated b-catenin levels and thereby tumourigenesis.
The involvement of PtdIns(4,5)P 2 and Amer1/WTX in LRP6 phosphorylation therefore adds additional layers of regulation to the two existing (and complementary) models of Wnt receptor activation (Figure 1) (MacDonald et al, 2009 ). In the 'initiation-amplification' model, Fz/Dvl recruitment of the Axin-GSK3 complex initiates PPPSPxS phosphorylation (initiation), which provides additional Axin-docking sites and thereby enhances further PPPSPxS phosphorylation (amplification) (MacDonald et al, 2009 ). In the 'signalosome' model, Dvl and Axin, via their ability to 'polymerize' through a unique domain (the DIX domain), provide a recruitment platform for Fz (hence LRP6) and Axin-GSK3 to form a receptor supercomplex in which LRP6 is phosphorylated (Bilic et al, 2007; Schwarz-Romond et al, 2007) . PtdIns(4,5)P 2 and Amer1/WTX apparently share or facilitate some of the Axin recruitment function of Dvl (Tanneberger et al, 2011) (Figure 1) . These results/models further raise an important question: as Dvl, Amer1/WTX, and phosphorylated LRP6 each can bind to Axin, are there discrete steps and roles of these Axin recruiting events/molecules? One speculation is that Dvl and Amer1/ WTX/PtdIns(4,5)P 2 may account for the first step and most of Axin recruitment to the plasma membrane, from which Axin is then recruited to phosphorylated LRP6 that leads to inhibition of b-catenin phosphorylation (MacDonald et al, 2009 ). Consistently, Axin recruitment to the plasma membrane primarily depends on Dvl and/or Amer1/WTX but not GSK3 and its phosphorylation of LRP6 (Cliffe et al, 2003; Tanneberger et al, 2011) .
While the Wnt/b-catenin pathway and core components are conserved among invertebrates and vertebrates, Amer1/ WTX is present only in vertebrates. Invertebrates such as Drosophila may rely on Dvl to recruit Axin whereas in vertebrates Amer1/WTX appears to delegate a part of the task in parallel (Figure 1) . One may ask whether the role of PtdIns(4,5)P 2 and PI4K/PIP5K in Wnt signalling is shared by invertebrates? Related to this issue, WTX loss-of-function mutations underlie the X-linked dominant disease osteopathia striata with cranial sclerosis (OSCS), which is characterized by excessive and hardened bone and other anomalies (Jenkins et al, 2009) . A male patient who is almost certainly null for WTX is still alive in teens (Perdu et al, 2010) . Thus, at least in some cases a lack of WTX provides quasinormal Wnt signalling compatible with embryonic development and the postnatal life. Another puzzle is that OSCS patients do not appear to have increased cancer risk, implying that sporadic WTX loss in somatic cells and inherited loss of WTX from the germline have distinct consequences (Jenkins et al, 2009 ). Amer1/WTX represents likely a vertebrate innovation for fine-tuning Wnt signalling both positively and negatively, and exhibits critical roles that are yet to be understood in cancer and disease pathogenesis.
